Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis.
暂无分享,去创建一个
M. E. Mandour | D. Harron | J. Bennett | W. Leahey | M. Homeida | H. M. Ali | H. el Turabi | T. el Sadig | M. Mandour | Mamoun M. A. Homeida | Mohammed El M. Mandour | Hamid El Turabi | Taha el Sadig | Hassan M. Ali | James L. Bennett | William J. Leahey | D. W. G. Harron
[1] A. Fenwick,et al. EFFECT OF ANTISCHISTOSOMAL CHEMOTHERAPY ON PREVALENCE OF SYMMERS' PERIPORTAL FIBROSIS IN SUDANESE VILLAGES , 1988, The Lancet.
[2] O. P. Shukla,et al. Altered drug metabolism in parasitic diseases. , 1988, Parasitology today.
[3] T. Nash,et al. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. , 1988, The American journal of tropical medicine and hygiene.
[4] J. R. Cançado,et al. Therapeutical evaluation of different dose regimens of praziquantel in schistosomiasis mansoni, based on the quantitative oogram technique. , 1987, Revista do Instituto de Medicina Tropical de Sao Paulo.
[5] D. Harron,et al. Propranolol disposition in patients with hepatosplenic schistosomiasis. , 1987, British journal of clinical pharmacology.
[6] T. Walle,et al. Increased clearance of propranolol and theophylline by high‐protein compared with high‐carbohydrate diet , 1987, Clinical pharmacology and therapeutics.
[7] S. Sulaiman,et al. Oltipraz: administration with food increases its anti-schistosomal activity. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[8] D. Back,et al. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis. , 1985, British journal of clinical pharmacology.
[9] R. Spector,et al. The effect of dietary protein on the clearance of allopurinol and oxypurinol. , 1985, The New England journal of medicine.
[10] E. Aa. The Blue Nile Health Project: a comprehensive approach to the prevention and control of water-associated diseases in irrigated schemes of the Sudan. , 1985, The Journal of tropical medicine and hygiene.
[11] T. Nash,et al. Schistosome infections in humans: perspectives and recent findings. NIH conference. , 1982, Annals of internal medicine.
[12] H. Frohberg,et al. Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides. , 1981, Arzneimittel-Forschung.
[13] P. Jordan,et al. Schistosomiasis transmission with particular reference to possible ecological and biological methods of control. A review. , 1980, Acta tropica.
[14] A. Conney,et al. Nutrition and oxidative drug metabolism in man: Relative influence of dietary lipids, carbohydrate, and protein , 1979, Clinical pharmacology and therapeutics.
[15] A. Prata,et al. Altered drug metabolism in hepatosplenic schistosomiasis. , 1979, Revista do Instituto de Medicina Tropical de Sao Paulo.
[16] K. Warren,et al. Control of schistosomiasis: report of a workshop. , 1979, The American journal of tropical medicine and hygiene.
[17] E. Vesell,et al. Unaltered metabolism of antipyrine and tolbutamide in fasting man , 1975, Clinical pharmacology and therapeutics.